Saccà S, Pascotto A, Siniscalchi C, Rolando M
Department of Neurological and Visual Sciences, University of Genoa, Ospedale San Martino, Italy.
J Ocul Pharmacol Ther. 2001 Apr;17(2):107-13. doi: 10.1089/10807680151125393.
The purpose of this study was to report paradoxical reaction on the intraocular pressure after treatment with latanoprost in 3 cases of uveitic glaucoma. Serial clinical examinations of intraocular pressure by means of daily tonometric curves were performed in three patients with uveitic glaucoma before and after the beginning of latanoprost therapy. All measurements were performed by two doctors, but every patient's IOP was always measured by the same doctor. Adverse reactions, such as increased intraocular pressure and recurrence of inflammation, were noted to occur 7 to 16 days after rechallenging with topical latanoprost therapy for glaucoma in patients with history of uveitic glaucoma. The conclusion indicates that clinicians should be alerted to these possible complications of topical latanoprost therapy in uveitic glaucoma.
本研究的目的是报告3例葡萄膜炎性青光眼患者在用拉坦前列素治疗后眼压出现的反常反应。对3例葡萄膜炎性青光眼患者在开始拉坦前列素治疗之前及之后,通过每日眼压曲线进行眼压的系列临床检查。所有测量均由两名医生进行,但每位患者的眼压始终由同一名医生测量。对于有葡萄膜炎性青光眼病史的患者,在用局部拉坦前列素治疗青光眼再次激发后7至16天,出现了眼压升高和炎症复发等不良反应。结论表明,临床医生应警惕局部拉坦前列素治疗葡萄膜炎性青光眼时这些可能的并发症。